... identified a gene ?and the molecular function of ...ue to further understanding obesity and may point ..., The scientists found that the human protein know... activity may be an important pharmaceutical targe...conditions that range from obesity to the loss of ...
...a risk for gastrointestinal illness, most visitors...d prevent infection. In addition, some engage in b...on according to several studies being presented th...g Infectious Diseases. , Researchers from the CDC... of an outbreak of , E. coli O157:H7 associated ...
...ail of scents when they are attacked by certain pe...otton leaf worm. , Parasitic wasps use these plant...eir eggs on it, so that their offspring can feed o...es and the plant is relieved from its attacker. In... activated to attract the parasitic wasps. This ge...
Other Biology News:Rutgers researchers find fat gene 2Common practices at petting zoos put visitors at risk 2New possibilities to fight pests with biological means 2(Date:11/30/2009)... international team of applied scientists from Har...nstrated compact, multibeam, and multi-wavelength ... spectrum (infrared). By contrast, typical lasers ...gth. The innovative multibeam lasers have potentia...ensing pollution monitoring, optical wireless, and...
(Date:11/30/2009)...wswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ...y that the company will be presenting at the 21st ...2009 at 12:30 pm local time at The New York Palace...he company,s business strategy, research and devel...o the live audio only presentation can be accessed...
(Date:11/30/2009)...S ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/ --,...Board: CYXN; ,China Yongxin,Pharmaceuticals, or ,t...and,retailer of pharmaceuticals in Northeastern Ch...for distribution of medicines on the Essential Dru... formalized the nation,s Essential Drug,List which...
(Date:11/30/2009)...wire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (... class of platinum-based anti-tumor compounds, ter...umor potency and activity compared to currently av...ility to overcome cisplatin-resistance in cancer c...titled "Novel Bis-platinum Complexes Endowed with ...
Breaking Biology Technology:Scientists demonstrate multibeam, multi-functional lasers 2NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3...AIN VIEW, Calif., March 12 Alexza,Pharmaceuticals...ll release,results for its fiscal year ended Decem...the close of the U.S. financial markets. The Compa...s the financial results and other,clinical develop...ay. A,replay of the call will be available for two...
...ded Agreement Accelerates Expected Timing of Final...le Powering of Interim and Final Results-, -Dendre...2008 at 11:00 AM ...daq: DNDN ) today announced that the U.S. Food an...ed Special Protocol Assessment (SPA) for the,Phase...
...nds PDE10 Collaboration with Amgen- -Com...ONTVALE, N.J., March 12 Memory,Pharmaceuticals Co...ealigned,its operations, reallocated its resources...its PDE10 collaboration with Amgen. The Company wi...o partnered programs, its,nicotinic alpha-7 recept...
Other Biology Technology:Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008 2Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008 3FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE 2FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE 3FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE 4Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 2Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 3Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 4Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 5Fingerprinting II Informatix, optional matrix types module from Bio-Rad
... Lines ,High Quality, Functionally-Validated, Ion ...for having a critical role in nerve and muscle fun..., CNS and the heart. Drugs that modulate ion chann...uch as neuropathic pain, cardiac arrhythmia, hyper...
...are derived from frozen embedded tissue blocks, wh...edures to ensure the highest quality. Tissues of e...tioned at a thickness of 7 microns and mounted on ...ter) in comparison to core sections made using Tis...
...ations or for use in an automated line. The StatMa...fold provides greater ease, speed, convenience, an...StatMatic II can be connected to a range of bottle...ne-handed operation -- in a matter of seconds.,T...
Biology Products: